Role of Complement in HIV and SIV Pathogenesis and Immunity

作者: D. C. Montefiori

DOI: 10.1007/978-3-642-79896-2_4

关键词:

摘要: The complement system is comprised of a group proteins and receptors that mediate inflammation play an important role in phagocytosis lysis microorganisms (Muller-Eberhard 1988). To defend against virus infection, activated fragments component C3 (i.e., C3b, C3dg, C3d) become deposited on the surface, which then target for clearance through mononuclear phagocytic (Frank Fries 1991). Alternatively, activation may lead to assembly membrane attack complex (MAC) causing neutralization by (Hirsch 1982). Complement be directly surface epitopes impair ability factor H negatively control amplification alternative pathway C3b,Bb convertase (Fearon 1978; Pangburn et al. 1980). This type can blocked sialylation carbohydrate moieties found 1978). also Fc region antibodies bound (Schumaker 1976).

参考文章(150)
K F Austen, P F Weller, A Nicholson-Weller, J Burge, D T Fearon, Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. Journal of Immunology. ,vol. 129, pp. 184- 189 ,(1982)
M Kirschfink, M Kröpelin, C Süsal, G Opelz, V Daniel, Complement activation by recombinant HIV-1 glycoprotein gp120. Journal of Immunology. ,vol. 152, pp. 6028- 6034 ,(1994)
H Geyer, C Holschbach, G Hunsmann, J Schneider, Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. Journal of Biological Chemistry. ,vol. 263, pp. 11760- 11767 ,(1988) , 10.1016/S0021-9258(18)37849-9
George C. Tsokos, John D. Lambris, Carl H. June, Fred D. Finkelman, Evangelos D. Anastassiou, Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. Journal of Immunology. ,vol. 144, pp. 1640- 1645 ,(1990)
W E Robinson, M K Gorny, J Y Xu, W M Mitchell, S Zolla-Pazner, Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. Journal of Virology. ,vol. 65, pp. 4169- 4176 ,(1991) , 10.1128/JVI.65.8.4169-4176.1991
M O Spycher, R H Carter, R Hoffman, Y C Ng, D T Fearon, Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. Journal of Immunology. ,vol. 141, pp. 457- 463 ,(1988)
C D Weiss, J A Levy, J M White, Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. Journal of Virology. ,vol. 64, pp. 5674- 5677 ,(1990) , 10.1128/JVI.64.11.5674-5677.1990
W E Robinson, T Kawamura, D Lake, Y Masuho, W M Mitchell, E M Hersh, Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro Journal of Virology. ,vol. 64, pp. 5301- 5305 ,(1990) , 10.1128/JVI.64.11.5301-5305.1990
P P Shadduck, J B Weinberg, A F Haney, J A Bartlett, A J Langlois, D P Bolognesi, T J Matthews, Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages. Journal of Virology. ,vol. 65, pp. 4309- 4316 ,(1991) , 10.1128/JVI.65.8.4309-4316.1991